Skip to search formSkip to main contentSkip to account menu

hecolin

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Efficacy evaluation through human trials is crucial for advancing a vaccine candidate to clinics. Next-generation sequencing (NGS… 
Review
2018
Review
2018
ABSTRACT Hepatitis E virus (HEV) infection is an emerging zoonotic disease posing a severe threat to public health in the world… 
2017
2017
Globally, hepatitis E virus (HEV) is the most common cause of acute viral hepatitis. HEV is endemic in many developing countries… 
Highly Cited
2014
Highly Cited
2014
Immunity acquired from infection or vaccination protects humans from symptomatic hepatitis E. However, whether the risk of… 
2013
2013
A recombinant hepatitis E vaccine, Hecolin®, has been proven safe and effective in healthy adults. As hepatitis B surface antigen…